These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16212965)

  • 1. Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.
    Gómez-Hernández A; Martín-Ventura JL; Sánchez-Galán E; Vidal C; Ortego M; Blanco-Colio LM; Ortega L; Tuñón J; Egido J
    Atherosclerosis; 2006 Jul; 187(1):139-49. PubMed ID: 16212965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization.
    Gómez-Hernández A; Sánchez-Galán E; Martín-Ventura JL; Vidal C; Blanco-Colio LM; Ortego M; Vega M; Serrano J; Ortega L; Hernández G; Tunón J; Egido J
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):60-9. PubMed ID: 16424787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
    Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
    Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans.
    Cipollone F; Fazia M; Iezzi A; Ciabattoni G; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; De Luca M; Prontera C; Chiarelli F; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1259-65. PubMed ID: 15155382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
    Cipollone F; Fazia ML; Iezzi A; Cuccurullo C; De Cesare D; Ucchino S; Spigonardo F; Marchetti A; Buttitta F; Paloscia L; Mascellanti M; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1925-31. PubMed ID: 16020747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages.
    Díaz-Muñoz MD; Osma-García IC; Cacheiro-Llaguno C; Fresno M; Iñiguez MA
    Cell Signal; 2010 Oct; 22(10):1427-36. PubMed ID: 20546888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
    Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
    Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COX-2 and mPGES-1 expression in carotid atherosclerotic plaques].
    Liu HF; Li XH; Yang QD; Miao W; Qi SS; Song XM; He GS; Dong HL; Zhang FQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):453-6. PubMed ID: 17680542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.
    Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Gómez-Hernández A; Arribas A; Ortega L; Tuñón J; Egido J
    Stroke; 2004 Feb; 35(2):458-63. PubMed ID: 14739407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts.
    Båge T; Lindberg J; Lundeberg J; Modéer T; Yucel-Lindberg T
    BMC Genomics; 2010 Apr; 11():241. PubMed ID: 20398340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.
    Korotkova M; Westman M; Gheorghe KR; af Klint E; Trollmo C; Ulfgren AK; Klareskog L; Jakobsson PJ
    Arthritis Rheum; 2005 Nov; 52(11):3439-47. PubMed ID: 16255020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes.
    Nah SS; Choi IY; Lee CK; Oh JS; Kim YG; Moon HB; Yoo B
    Rheumatology (Oxford); 2008 Apr; 47(4):425-31. PubMed ID: 18285354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Areca nut extracts increased the expression of cyclooxygenase-2, prostaglandin E2 and interleukin-1α in human immune cells via oxidative stress.
    Chang LY; Wan HC; Lai YL; Chou IC; Chen YT; Hung SL
    Arch Oral Biol; 2013 Oct; 58(10):1523-31. PubMed ID: 23916228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.
    Cipollone F; Fazia M; Iezzi A; Zucchelli M; Pini B; De Cesare D; Ucchino S; Spigonardo F; Bajocchi G; Bei R; Muraro R; Artese L; Piattelli A; Chiarelli F; Cuccurullo F; Mezzetti A
    Circulation; 2003 Mar; 107(11):1479-85. PubMed ID: 12654603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
    Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
    Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells.
    Xue J; Hua YN; Xie ML; Gu ZL
    Biomed Pharmacother; 2010 Feb; 64(2):118-23. PubMed ID: 19880272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.
    Cipollone F; Prontera C; Pini B; Marini M; Fazia M; De Cesare D; Iezzi A; Ucchino S; Boccoli G; Saba V; Chiarelli F; Cuccurullo F; Mezzetti A
    Circulation; 2001 Aug; 104(8):921-7. PubMed ID: 11514380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of prostaglandin E2 synthases and E-prostanoid receptors in the spinal cord in a rat model of neuropathic pain.
    Kanda H; Kobayashi K; Yamanaka H; Okubo M; Dai Y; Noguchi K
    Brain Res; 2021 Jan; 1750():147153. PubMed ID: 33049240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.